Accogli Giuseppe 4
4 · BAXTER INTERNATIONAL INC · Filed Jun 23, 2020
Insider Transaction Report
Form 4
Accogli Giuseppe
CVP, Renal
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-06-19−8,334→ 0 totalExercise: $46.18Exp: 2026-09-01→ Common Stock, $1 par value (8,334 underlying) - Exercise/Conversion
Stock Option [Right to Buy)
2020-06-19−62,388→ 31,195 totalExercise: $50.77Exp: 2027-03-02→ Common Stock, $1 par value (62,388 underlying) - Exercise/Conversion
Common Stock, $1 par value
2020-06-19$46.18/sh+8,334$384,864→ 76,473 total - Sale
Common Stock, $1 par value
2020-06-19$85.00/sh−72,341$6,148,985→ 66,520 total - Exercise/Conversion
Common Stock, $1 par value
2020-06-19$50.77/sh+62,388$3,167,439→ 138,861 total
Footnotes (3)
- [F1]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to certain vested stock options, restricted stock units, and performance share units previously granted by Baxter International Inc. to Mr. Accogli.
- [F2]The options become exercisable in three equal annual installments beginning on September 1, 2017, the first anniversary of the grant date.
- [F3]The options become exercisable in three equal annual installments beginning on March 2, 2018, the first anniversary of the grant date.